{
  "nct_id": "NCT85359681",
  "indication": "Hypertension",
  "phase": "Phase 2",
  "sample_size": 349,
  "duration_weeks": 37,
  "dropout_rate": 0.43,
  "primary_endpoints": [
    "CV events reduction"
  ],
  "secondary_endpoints": [
    "CV events reduction",
    "SBP reduction"
  ],
  "blinding": "double-blind",
  "control_arm": "placebo",
  "outcome_summary": "Study did not meet primary efficacy endpoints.",
  "success": false,
  "failure_reason": "Low compliance/adherence"
}